Azurity Pharmaceuticals announces FDA approval of Eprontia (topiramate) oral solution

Azurity Pharmaceuticals

8 November 2021 - The first and only FDA approved ready to use liquid topiramate.

Azurity Pharmaceuticals today announced the U.S. FDA approval of Eprontia (topiramate) 25 mg/mL oral solution.

Read Azurity Pharmaceuticals press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US